BMO Raises BrightSpring Health Price Target to $84
The target increase and stated momentum are bullish, though the size of the target revision is not provided and the price target remains an analyst opinion.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The target increase and stated momentum are bullish, though the size of the target revision is not provided and the price target remains an analyst opinion.
What happened, with direct paths to the underlying reporting
BMO raised its BTSG price target to $84 versus the posted price of $69.76, citing continuing LDD momentum into Q4. The shares were up 0.18% since the signal.
Target: $84
Posted price: $69.76
Analyst firm: BMO Capital
Analyst: Sean Dodge
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.